I serve companies looking to establish or scale their footprint in the complex European landscape, building sustainable market leadership through proven commercial excellence.

• At BD Bioscience, I established EMEA delivering 10% growth above the market average for the BD Rhapsody™ portfolio.

• I recruited and led the initial commercial team to establish a MultiOmics presence in Europe, achieving the #1 regional position worldwide within the first year

I provide board-level insights and high-impact collaboration for executive opportunities, focusing on disruptive genomic trends like Spatial Biology and Clinical Multiomics.

• I established NGS as a leading technology during the EHEC outbreak, establishing a landmark in genomic application.

• I guided the integration of next-gen workflows into clinical and Pharma environments, ensuring complex innovations deliver actionable results for oncology and precision medicine.

I help organizations pioneer novel customer engagement architectures, utilizing digital transformation to set new industry standards.

• I implemented AI driven digital engagement strategies like "BD FACS University" to establish high-parameter, high level life sciences customer support

• I pioneered "virtualBD," a metaverse-based customer sales and support platform to drive immersive digital engagement, seting a new standard for customer engagement

I redesign Go-To-Market (GTM) strategies to ensure that technical engagement drives commercial velocity, especially when transitioning RUO (Research Use Only) portfolios into clinical-grade applications.

• I achieved 40–60% market penetration within 12 months of launch via the "Falcon Team" approach at Thermo Fisher Scientific.

• I led the development and commercial release of 6 clinical NGS panels by integrating global Key Opinion Leader (KOL) networks

I specialize in change management, transitioning traditional departments into high performing customer-centric units that foster an "entrepreneurship spirit" within large corporate structures.

• I led a large-scale organization of over 90 FTEs, transforming the department into a high-performance unit that consistently exceeded growth targets.

• I revolutionized product management by integrating agile principles and KOL insights directly into the product development pipeline.